Seegene Submits Allplex SARS-CoV-2/FluA/FluB/RSV Assay for FDA EUA
The real-time RT-PCR assay from Seegene differentiates influenza A and B, RSV, and three different target genes of covid-19.
Read MorePosted by Melanie Hamilton-Basich | Mar 23, 2021 | Covid 19 |
The real-time RT-PCR assay from Seegene differentiates influenza A and B, RSV, and three different target genes of covid-19.
Read MorePosted by Laurie Bonner | Mar 23, 2021 | Covid 19 |
“If we can work together to strengthen our collaborations, ensure access to resources, and provide adequate funding, we will be in a much better position to respond to not only this current pandemic but all future outbreaks.”—Frederick S. Nolte, PhD
Read MorePosted by Laurie Bonner | Mar 23, 2021 | Covid 19, Molecular Diagnostics |
New web-based platform, developed with NIH funding, will aid in monitoring emerging SARS-CoV-2 variants and the performance of diagnostic tests.
Read MorePosted by Melanie Hamilton-Basich | Mar 22, 2021 | Covid 19 |
The partnership will work toward CE marking of Aptamer Group’s AptaDx SARS-CoV-2 lateral flow rapid antigen test for professional use, to detect the SARS-CoV-2 spike protein antigen in anterior nasal swabs.
Read MorePosted by Laurie Bonner | Mar 22, 2021 | Covid 19 |
What “silver linings” has the pandemic response brought to you and your lab? What changes have occurred, for better or for worse, where you work?
Read More